Necrotising Scleritis Post Trans-Scleral Diode Cyclophotocoagulation-A Novel Approach
|Vipul Bhandari1,2*, Jnaneshwar Prasanna1,2, Pankaj Bendale1,2, Aditya Kelkar1,2, Anand Doraisamy1,2, and Shylaja1,2|
|1Vasan eye centre, Rajajinagar, Bangalore, India|
|2National Institute of Ophthalmology, Pune, India|
|Corresponding Author :||Dr. Vipul Bhandari
Vasan eye centre, rajajinagar, Bangalore, India
E-mail: [email protected]
|Received February 15, 2015; Accepted March 30, 2015; Published April 01, 2015|
|Citation: Bhandari V, Prasanna J, Bendale P, Kelkar A, Doraisamy A, Shylaja (2015) Necrotising Scleritis Post Trans-Scleral Diode Cyclophotocoagulation-A Novel Approach . J Clin Exp Ophthalmol 6:412. doi: 10.4172/2155-9570.1000412|
|Copyright: © 2015 Bhandari V, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.|
|Related article at
Pubmed Scholar Google
Introduction: Surgically induced necrotizing sclerokeratitis (SINS) is a destructive form of scleritis. Presentation of Case: We report two cases of necrotising scleritis after inferior 180 degrees trans-scleral cyclophotocoagulation (TSCPC). Both patients presented after one week with symptoms of pain and redness. We tried a novel therapy of surgical patch graft rather than systemic steroid therapy.
Discussion: High dose pulse systemic steroid with gradual tapering is the initial treatment for which majority cases respond. Some cases do require systemic immunosuppression by drugs other than steroids. We tried a novel therapy of surgical patch graft rather than systemic steroid therapy.
Conclusion: Scleral patch graft is a novel treatment in the management of post-TSCPC SINS.